Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 1/2 1

Status

Recruiting 4Completed 2Not yet recruiting 1

Sponsor Class

INDUSTRY 7

Study Type

Interventional 7

Sponsor

Conditions

Breast Neoplasms 3092Neoplasms 2436Carcinoma, Non-Small-Cell Lung 1863Prostatic Neoplasms 1617Colorectal Neoplasms 1422Lung Neoplasms 1292Multiple Myeloma 927Neoplasm Metastasis 919Leukemia, Myeloid, Acute 874Pancreatic Neoplasms 847Ovarian Neoplasms 799Melanoma 783Carcinoma, Hepatocellular 736Stomach Neoplasms 639Brain Neoplasms 635Recurrence 633Squamous Cell Carcinoma of Head and Neck 630Head and Neck Neoplasms 609Glioblastoma 566Lymphoma 539Uterine Cervical Neoplasms 537Triple Negative Breast Neoplasms 504Precursor Cell Lymphoblastic Leukemia-Lymphoma 499Carcinoma, Renal Cell 497Hematologic Neoplasms 462Urinary Bladder Neoplasms 459Endometrial Neoplasms 459Colonic Neoplasms 441Lymphoma, Non-Hodgkin 435Sarcoma 434

Interventions

Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Advanced Tumors × 1 year × Clear all
NCT07629258 2026-06-05

GW01-200-01

Groovy Medicine (Hangzhou) Ltd.

Phase 1 Not yet recruiting
100 enrolled

Advanced Tumors

NCT06245122 2026-04-06

A Study of CS23546 in Subjects With Advanced Tumors

Chipscreen Biosciences, Ltd.

Phase 1 Recruiting
156 enrolled

Advanced Tumors

NCT07110584 2026-03-05

Dose Escalation and Dose Expansion Study of MDX2004 in Participants With Advanced Tumors

ModeX Therapeutics, An OPKO Health Company

Phase 1/2 Recruiting
235 enrolled

Advanced Tumors

NCT07205198 2026-01-08

A Clinical Trial of SIBP-A10 Injection in the Treatment of Advanced Malignant Tumor Subjects.

Shanghai Institute Of Biological Products

Phase 1 Recruiting
160 enrolled

Advanced Tumors

NCT07179081 2025-09-17

A Study of AL58805 in Patients With Advanced Tumors

Advenchen Laboratories, LLC

Phase 1 Recruiting
40 enrolled

Advanced Tumors

NCT03444714 2025-09-15

Phase I Study of RiMO-301 With Radiation in Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
32 enrolled

Advanced Tumors

NCT05429008 2025-06-18

A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm

Hutchmed

Phase 1 Completed
40 enrolled

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡